Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-03-19

Clinical Trial Update: Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial of eus-guided cryothermal ablation in pancreatic adenocarcinoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 3 | Status: WITHDRAWN